Barclays PLC Has $929,000 Stake in CorVel Co. (NASDAQ:CRVL)

Barclays PLC grew its holdings in CorVel Co. (NASDAQ:CRVL) by 8.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,799 shares of the business services provider’s stock after purchasing an additional 361 shares during the period. Barclays PLC’s holdings in CorVel were worth $929,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. Kayne Anderson Rudnick Investment Management LLC increased its holdings in CorVel by 3.9% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,976,764 shares of the business services provider’s stock worth $376,139,000 after buying an additional 74,446 shares during the last quarter. BlackRock Inc. increased its holdings in CorVel by 0.3% in the first quarter. BlackRock Inc. now owns 1,501,735 shares of the business services provider’s stock worth $252,952,000 after buying an additional 3,908 shares during the last quarter. Vanguard Group Inc. increased its holdings in CorVel by 0.6% in the third quarter. Vanguard Group Inc. now owns 1,149,174 shares of the business services provider’s stock worth $159,079,000 after buying an additional 7,408 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in CorVel by 0.4% in the first quarter. Dimensional Fund Advisors LP now owns 632,668 shares of the business services provider’s stock worth $106,567,000 after buying an additional 2,801 shares during the last quarter. Finally, State Street Corp increased its holdings in CorVel by 0.8% in the first quarter. State Street Corp now owns 340,084 shares of the business services provider’s stock worth $64,711,000 after buying an additional 2,765 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on CorVel in a report on Thursday, October 5th. They set a “buy” rating on the stock.

Insider Activity

In other news, Chairman V Gordon Clemons sold 8,000 shares of the stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $210.44, for a total value of $1,683,520.00. Following the completion of the sale, the chairman now directly owns 323,534 shares of the company’s stock, valued at $68,084,494.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last three months, insiders sold 17,021 shares of company stock valued at $3,544,240. 48.71% of the stock is owned by company insiders.

CorVel Stock Down 0.0 %

Shares of CRVL stock opened at $213.96 on Tuesday. CorVel Co. has a 12 month low of $136.22 and a 12 month high of $228.94. The business’s 50 day moving average is $199.26 and its two-hundred day moving average is $203.63. The company has a market cap of $3.66 billion, a PE ratio of 49.87 and a beta of 1.06.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings results on Monday, October 30th. The business services provider reported $1.15 EPS for the quarter. CorVel had a return on equity of 36.16% and a net margin of 9.95%. The company had revenue of $195.52 million for the quarter.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.